Portugal – Pharmaceutical products – 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] vs Portugal – Reagents and contrast media – Fornecimento de reagentes e tecnologia para a UIPM e LHO
Side-by-side comparison of two grants.
| Attribute | Portugal – Pharmaceutical products – 2023/0491 - VEDOLIZUMAB [300 MG PÓ CONC SOL INJ FRS] | Portugal – Reagents and contrast media – Fornecimento de reagentes e tecnologia para a UIPM e LHO |
|---|---|---|
| Type | Tender | Tender |
| Funding amount | $221K | $722K |
| Deadline | — | Closes 2026-08-14 |
| Region | PRT | PRT |
| Sector | Health | Health |
| Funder | Unidade Local de Saúde Santa Maria, E.P.E. | Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE |
| Who it's for | — | — |